2022
DOI: 10.1016/j.htct.2022.01.017
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 induced follicular lymphoma remission

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…There are few case reports about lymphoma remissions after bacterial or virus infections, including recently the SARs-CoV-2 infection, suggesting that the infection can trigger the immune system against the tumor cell. Although there is none associated with vaccination, there are no cases reported yet ( 12 , 13 ).…”
Section: Discussionmentioning
confidence: 99%
“…There are few case reports about lymphoma remissions after bacterial or virus infections, including recently the SARs-CoV-2 infection, suggesting that the infection can trigger the immune system against the tumor cell. Although there is none associated with vaccination, there are no cases reported yet ( 12 , 13 ).…”
Section: Discussionmentioning
confidence: 99%
“…Reported cases included patients diagnosed with lymphoma, multiple myeloma, chronic lymphocytic leukemia, renal cell carcinoma, and colorectal carcinoma, with most of the cases related to hematologic neoplasms, suggesting higher spontaneous remission rates for these malignancies. 2,[5][6][7][8][9][10] Extended patient follow-up and research are required to fully understand the molecular mechanisms, confirm the relationship between COVID-19 disease and cancer, and determine the clinical implications of these interactions. 5…”
mentioning
confidence: 99%
“…Over the last 3 years, a limited number of cases describing the antitumor effect of SARS-CoV-2 have been reported in the literature, with only a small part of these involving patients who did not receive any antineoplastic treatment. Reported cases included patients diagnosed with lymphoma, multiple myeloma, chronic lymphocytic leukemia, renal cell carcinoma, and colorectal carcinoma, with most of the cases related to hematologic neoplasms, suggesting higher spontaneous remission rates for these malignancies 2,5–10 . Extended patient follow-up and research are required to fully understand the molecular mechanisms, confirm the relationship between COVID-19 disease and cancer, and determine the clinical implications of these interactions 5 …”
mentioning
confidence: 99%